Project to develop human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in patients , approved by CSIR

CSIR through NMITLI program has approved a project towards development of human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in patients. This project on generation of neutralizing human monoclonal antibodies as a therapeutic strategy will be implemented by a multi-institutional and multi-disciplinary team. The team comprises of academic institutes and industry with participants from NCCS, […]

Read More